Tumor development is a Darwinian evolutionary process, involving the interplay between
cancer subclones and the local immune microenvironment. These complex interactions are
highlighted in this issue of Cell by the results from Jiménez-Sánchez et al. of a deep analysis
of one patient with advanced serous carcinoma of the ovary.